SI1381605T1 - Mercaptoacetylamide derivatives, a process for their preparation and their use - Google Patents

Mercaptoacetylamide derivatives, a process for their preparation and their use

Info

Publication number
SI1381605T1
SI1381605T1 SI200230089T SI200230089T SI1381605T1 SI 1381605 T1 SI1381605 T1 SI 1381605T1 SI 200230089 T SI200230089 T SI 200230089T SI 200230089 T SI200230089 T SI 200230089T SI 1381605 T1 SI1381605 T1 SI 1381605T1
Authority
SI
Slovenia
Prior art keywords
compounds
preparation
disclosed
mercaptoacetylamide derivatives
mercaptoacetylamide
Prior art date
Application number
SI200230089T
Other languages
English (en)
Slovenian (sl)
Inventor
Gary A. Flynn
Shujaath Mehdi
Jack Roger Koehl
Barbara Ann Anderson
Manfred Gerken
Bernd Jablonka
Heinz-Werner Kleemann
Wolfgang Linz
Werner Seiz
Bernhard Seuring
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of SI1381605T1 publication Critical patent/SI1381605T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cephalosporin Compounds (AREA)
SI200230089T 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use SI1381605T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28330501P 2001-04-12 2001-04-12
GBGB0119305.1A GB0119305D0 (en) 2001-04-12 2001-08-08 Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (en) 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use

Publications (1)

Publication Number Publication Date
SI1381605T1 true SI1381605T1 (en) 2005-06-30

Family

ID=26246410

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230089T SI1381605T1 (en) 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use

Country Status (26)

Country Link
EP (1) EP1381605B1 (cs)
JP (1) JP4392167B2 (cs)
CN (1) CN1245404C (cs)
AT (1) ATE286898T1 (cs)
AU (1) AU2002304804B2 (cs)
BG (1) BG66387B1 (cs)
BR (1) BR0208889A (cs)
CA (1) CA2443488C (cs)
CZ (1) CZ299708B6 (cs)
DE (1) DE60202602T2 (cs)
EE (1) EE05272B1 (cs)
ES (1) ES2232752T3 (cs)
HR (1) HRP20030823B1 (cs)
HU (1) HU229612B1 (cs)
IL (1) IL158289A0 (cs)
MA (1) MA26098A1 (cs)
MX (1) MXPA03008613A (cs)
NO (1) NO325655B1 (cs)
NZ (1) NZ528825A (cs)
OA (1) OA12502A (cs)
PL (1) PL209338B1 (cs)
PT (1) PT1381605E (cs)
RU (1) RU2286346C2 (cs)
SI (1) SI1381605T1 (cs)
SK (1) SK287616B6 (cs)
WO (1) WO2002083671A1 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
DE69220744T2 (de) * 1991-09-27 1997-11-13 Merrell Pharma Inc 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
RU2127261C1 (ru) * 1993-06-11 1999-03-10 Эйсаи Ко., ЛТД Производные аминокислоты
WO1994028901A1 (en) * 1993-06-11 1994-12-22 Eisai Co., Ltd. Amino acid derivative

Also Published As

Publication number Publication date
ES2232752T3 (es) 2005-06-01
SK287616B6 (sk) 2011-04-05
NO325655B1 (no) 2008-06-30
CA2443488C (en) 2011-05-31
JP4392167B2 (ja) 2009-12-24
EE05272B1 (et) 2010-02-15
RU2003132875A (ru) 2005-03-20
DE60202602T2 (de) 2006-03-23
PL209338B1 (pl) 2011-08-31
DE60202602D1 (de) 2005-02-17
WO2002083671A1 (en) 2002-10-24
HRP20030823B1 (en) 2011-10-31
HU229612B1 (en) 2014-03-28
MXPA03008613A (es) 2003-12-08
NO20034412L (no) 2003-10-02
HRP20030823A2 (en) 2005-08-31
AU2002304804B2 (en) 2007-05-10
EP1381605B1 (en) 2005-01-12
EE200300500A (et) 2003-12-15
CZ299708B6 (cs) 2008-10-29
PL363034A1 (en) 2004-11-15
HK1061690A1 (en) 2004-09-30
MA26098A1 (fr) 2004-04-01
IL158289A0 (en) 2004-05-12
HUP0303482A3 (en) 2012-12-28
BR0208889A (pt) 2004-06-29
CZ20032722A3 (cs) 2004-01-14
PT1381605E (pt) 2005-03-31
NO20034412D0 (no) 2003-10-02
ATE286898T1 (de) 2005-01-15
BG108203A (bg) 2004-12-30
SK12552003A3 (sk) 2004-03-02
BG66387B1 (bg) 2013-11-29
EP1381605A1 (en) 2004-01-21
CN1245404C (zh) 2006-03-15
RU2286346C2 (ru) 2006-10-27
CN1501926A (zh) 2004-06-02
OA12502A (fr) 2006-05-29
CA2443488A1 (en) 2002-10-24
JP2004525966A (ja) 2004-08-26
NZ528825A (en) 2005-04-29
HUP0303482A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
TNSN03083A1 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
MY142109A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
WO2004011453A3 (en) Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
WO2003082857A3 (en) Lansoprazole polymorphs and processes for preparation thereof
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
WO2002065834A3 (en) Novel formulations of carvedilol
AP1766A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
YU61103A (sh) Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
WO2004032908A3 (en) Method of inhibiting angiogenesis
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
SG165159A1 (en) Process for preparing 6-alkylidene penem derivatives
WO2005051401A3 (en) Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol
IL158289A0 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
WO2003028645A3 (en) Novel compositions of carvedilol
PT1651596E (pt) Novos derivados de 4,4?-ditiobis-(3-aminobutano-1-sulfonatos) e composições que os contêm
AU2002326391A1 (en) Carvedilol polymorph
WO2002085877A3 (en) Processes and intermediates for preparing benzyl substituted epoxides
MXPA05003881A (es) Preparacion de compuestos triazospiro.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04002879A (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol.